Metraipolis › archive › dc_3badcc2d8912

Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab — Europe PMC PMID:42332483

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42332483
DOI
10.1097/md.0000000000049269
License (as archived)
solo-consultazione
Archived
2026-10-31T23:33:07.551Z
SHA-256 of the archived text
469d40989e18c474e2675880fcddbbf367fbf8d0b0bf9e7488ad960c731bd6e9
Stable URL of this page
https://metraipolis.com/documento/dc_3badcc2d8912

How to cite

Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab — Europe PMC PMID:42332483 — Europe PMC (en), https://europepmc.org/article/MED/42332483 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3badcc2d8912 (Metraipolis archive dc_3badcc2d8912, sha256 469d40989e18c474e2675880fcddbbf367fbf8d0b0bf9e7488ad960c731bd6e9)
BibTeX
@misc{dc3badcc2d8912,
  title = {Bezafibrate-associated rhabdomyolysis in a patient with diabetic kidney disease: A case report and successful transition to tafolecimab — Europe PMC PMID:42332483},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42332483},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3badcc2d8912; sha256 469d40989e18c474e2675880fcddbbf367fbf8d0b0bf9e7488ad960c731bd6e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42332483. Agents can read the archived copy with the MCP tool read_document.